These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29516890)

  • 61. Computationally Guided Identification of Novel Mycobacterium tuberculosis GlmU Inhibitory Leads, Their Optimization, and in Vitro Validation.
    Mehra R; Rani C; Mahajan P; Vishwakarma RA; Khan IA; Nargotra A
    ACS Comb Sci; 2016 Feb; 18(2):100-16. PubMed ID: 26812086
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis and evaluation of 4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] analogues against both active and dormant Mycobacterium tuberculosis.
    Alluri KK; Reshma RS; Suraparaju R; Gottapu S; Sriram D
    Bioorg Med Chem; 2018 May; 26(8):1462-1469. PubMed ID: 29501415
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
    Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
    Li P; Wang B; Zhang X; Batt SM; Besra GS; Zhang T; Ma C; Zhang D; Lin Z; Li G; Huang H; Lu Y
    Eur J Med Chem; 2018 Dec; 160():157-170. PubMed ID: 30336450
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structural requirements for the antitubercular quaternized triflupromazine pharmacophore.
    Kunciw DL; Liechty JJ; Mitchell MO; Wan B; Franzblau SG
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5679-80. PubMed ID: 22850215
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents.
    Desai NC; Trivedi AR; Somani HC; Bhatt KA
    Chem Biol Drug Des; 2015 Sep; 86(3):370-7. PubMed ID: 25534154
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis of novel pleuromutilin derivatives. Part 1: preliminary studies of antituberculosis activity.
    Dong YJ; Meng ZH; Mi YQ; Zhang C; Cui ZH; Wang P; Xu ZB
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1799-1803. PubMed ID: 25736994
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea.
    Sriram D; Yogeeswari P; Madhu K
    Bioorg Med Chem Lett; 2006 Feb; 16(4):876-8. PubMed ID: 16303302
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of Phenoxyalkylbenzimidazoles with Antitubercular Activity.
    Chandrasekera NS; Alling T; Bailey MA; Files M; Early JV; Ollinger J; Ovechkina Y; Masquelin T; Desai PV; Cramer JW; Hipskind PA; Odingo JO; Parish T
    J Med Chem; 2015 Sep; 58(18):7273-85. PubMed ID: 26295286
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
    Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
    Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis.
    Matviiuk T; Mori G; Lherbet C; Rodriguez F; Pasca MR; Gorichko M; Guidetti B; Voitenko Z; Baltas M
    Eur J Med Chem; 2014 Jan; 71():46-52. PubMed ID: 24269516
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New 1-hydroxy-2-thiopyridine derivatives active against both replicating and dormant Mycobacterium tuberculosis.
    Salina EG; Ryabova O; Vocat A; Nikonenko B; Cole ST; Makarov V
    J Infect Chemother; 2017 Nov; 23(11):794-797. PubMed ID: 28527650
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis.
    Matviiuk T; Madacki J; Mori G; Orena BS; Menendez C; Kysil A; André-Barrès C; Rodriguez F; Korduláková J; Mallet-Ladeira S; Voitenko Z; Pasca MR; Lherbet C; Baltas M
    Eur J Med Chem; 2016 Nov; 123():462-475. PubMed ID: 27490025
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Discovery of novel acetohydroxyacid synthase inhibitors as active agents against Mycobacterium tuberculosis by virtual screening and bioassay.
    Wang D; Zhu X; Cui C; Dong M; Jiang H; Li Z; Liu Z; Zhu W; Wang JG
    J Chem Inf Model; 2013 Feb; 53(2):343-53. PubMed ID: 23316686
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages.
    Sorrentino F; Gonzalez del Rio R; Zheng X; Presa Matilla J; Torres Gomez P; Martinez Hoyos M; Perez Herran ME; Mendoza Losana A; Av-Gay Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):640-5. PubMed ID: 26503663
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.
    Lilienkampf A; Pieroni M; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2010 Jan; 53(2):678-88. PubMed ID: 20000577
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
    Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
    Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
    Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis and in vitro investigation of halogenated 1,3-bis(4-nitrophenyl)triazenide salts as antitubercular compounds.
    Torfs E; Vajs J; de Macedo MB; Cools F; Vanhoutte B; Gorbanev Y; Bogaerts A; Verschaeve L; Caljon G; Maes L; Delputte P; Cos P; Košmrlj J; Cappoen D
    Chem Biol Drug Des; 2018 Feb; 91(2):631-640. PubMed ID: 28845550
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A robust synthesis of functionalized 2H-indazoles via solid state melt reaction (SSMR) and their anti-tubercular activity.
    Vidyacharan S; Adhikari C; Krishna VS; Reshma RS; Sriram D; Sharada DS
    Bioorg Med Chem Lett; 2017 Apr; 27(7):1593-1597. PubMed ID: 28254485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.